A stock market run and a flurry of dealmaking have buoyed a sector that spent much of 2023 in a downturn. Can the momentum last?Guarded optimism seems to be the mood of the biopharmaceutical industry to start 2024.Last year brought a stock market slide and layoffs for more than 150 drug companies. Financial and regulatory […]
